Press Releases and Statements

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today following the adoption of Kentucky House Bill 386 into law, legislation that will eliminate the state’s annual purchase limit for common over-the-counter (OTC) cold and allergy medications containing the ingredient pseudoephedrine (PSE), which is currently the most restrictive yearly limit nationwide at 24 grams, or roughly a three-month supply.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association released the following statement today in response to draft guidance released from the U.S. Food and Drug Administration (FDA) on New Dietary Ingredient Notification (NDIN) Master Files for Dietary Supplements:

(AMELIA ISLAND, Fla.) – The Consumer Healthcare Products Association (CHPA) and its 501c3 educational arm – the Health In Hand Foundation – today announced the election of new board members to both organizations during the association’s annual Self-Care Leadership Summit (SLS) in Amelia Island, Florida this week.

(AMELIA ISLAND, Fla.) – The Consumer Healthcare Products Association (CHPA) awarded its Ivan D. Combe Lifetime Achievement Award to longtime industry leader Jeff Needham at the opening session of its annual Self-Care Leadership Summit (SLS) today in Florida. The Combe Award is the highest honor bestowed by the U.S. consumer healthcare industry, which recognizes the outstanding work and contributions of individuals whose lifetime of achievements have created a lasting impact on the industry, their community, and have directly improved self-care for consumers.

(WASHINGTON, D.C.) – Consumer Healthcare Products Association President and CEO Scott Melville released the below statement today in response to a letter from U.S. Senator Dick Durbin (D-IL) calling for modernization of the Dietary Supplement Health and Education Act (DSHEA) following the recent death of an Ohio man who ingested tianeptine, which is not an over-the-counter (OTC) medicine nor a dietary supplement, but an adulterant used by bad actors falsely marketing products as dietary supplements:

WASHINGTON, DC — Today, the Consumer Healthcare Products Association, the national trade association representing the leading manufacturers and marketers of consumer healthcare products, announced the addition of 41 new members since January 2023, a list which includes 15 manufacturer and 26 associate members, reflecting the broadening self-care landscape across over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices.

“Consumers can be confident that over-the-counter (OTC) acne products containing benzoyl peroxide (BPO) are stable and safe under the specified storage conditions on their labels.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the following statement today following West Virginia Governor Jim Justice signing Senate Bill (SB) 688 into law. This legislation lifts the annual purchasing limits for common over-the-counter cold and allergy

“While we’re pleased to see positive strides being made on this issue under Dr. Welch’s leadership, specifically when it comes to addressing procedures and timeframes

WASHINGTON, D.C. – Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released the below statement today following the U.S. House of Representatives passing H.R. 7024, the Tax Relief for American Families and Workers Act., a bipartisan, bicameral tax package that will expand the child tax credit and increase depreciation allowances to promote economic innovation and growth.

Congressmen Curtis, Cárdenas Spearhead Effort

CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement in response to results from a recent trial published in the American Journal of Clinical Nutrition (AJCN), finding that adults ages 60 and older who took a daily multivitamin (MVM) showed a “significantly more favorable change in episodic memory,” reducing cognitive aging by two years compared to those who took the placebo. These results mark the third time a MVM clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) has confirmed the positive benefits MVM’s have on older adults’ cognitive health.